Horizon Discovery Competitors and Similar CompaniesClear all

Horizon Discovery's competitors and similar companies include Lysogene, Lionex, Veritas and Genematrix.

	Horizon Discovery Horizon Discovery Group is a company that supplies genetically defined cell lines, in vivo models, reference standards, and contract research services to academia and biopharma.	Lysogene Lysogene is a company that provides research and clinical development of gene therapy for neurodegenerative disorders.	Lionex Lionex is a company that produces and supplies mycobacterial antigens and monoclonal antibodies for research.	Veritas Veritas Intercontinental (formerly known as Veritas Genetics) is a personal genomics company offering a genetic testing platform.	Genematrix Genematrix is a company that develops molecular diagnostic products.
Founding Date	Founding Date 2005	Founding Date 2009	Founding Date N/A	Founding Date 2014	Founding Date 2000
Type	Type Subsidiary	Type Private	Type Private	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech genetics medical diagnostics pharma platform	Tags Healthcare biotech genetics medical diagnostics pharma	Tags Healthcare biotech clinical research medical diagnostics pharma platform	Tags Healthcare biotech genetics healthtech medical diagnostics pharma platform	Tags Healthcare biotech drug development genetics medical diagnostics pharma
Locations	Locations Waterbeach, GB HQ Boyertown, US Lafayette, US St. Louis, US	Locations Neuilly-sur-Seine, FR HQ Cambridge, US	Locations Braunschweig, DE HQ	Locations Milano, IT HQ Sao Paulo, BR Bogotá, CO Barcelona, ES Madrid, ES	Locations Seongnam-si, KR HQ
Employees	Employees 114	Employees 22	Employees N/A	Employees 31	Employees N/A
Financial
Revenue (est.)	Revenue (est.) £62.9m (FY, 2019)	Revenue (est.) €3.7m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) $5m (Y, 2017)	Revenue (est.) ₩9.8b (FY, 2023)
Cost of goods	Cost of goods £12.6m (FY, 2019)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ₩4.5b (FY, 2023)
Gross profit	Gross profit £52.3m (FY, 2019)	Gross profit €7.2m (FY, 2021)	Gross profit N/A	Gross profit N/A	Gross profit ₩5.3b (FY, 2023)
Net income	Net income (£4.6m) (FY, 2019)	Net income (€13.6m) (FY, 2021)	Net income N/A	Net income N/A	Net income (₩894.9m) (FY, 2023)
Funding
Total funding raised	Total funding raised $ 50.2m	Total funding raised $ 22m	Total funding raised N/A	Total funding raised $ 51.7m	Total funding raised N/A